A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study

European Psychiatry

Volumn 31, Issue , 2016, Pages 20-28

  Daglas, R ^a,b   Cotton, S M ^a,b   Allott, K ^a,b   Yucel M ^c,d   Macneil, C A ^a   Hasty, M K ^a   Murphy, B ^d   Pantelis, C ^c,e   Hallam, K T ^f   Henry, L P ^a   Conus, P ^g   Ratheesh, A ^a,b   Kader, L ^a   Wong, M T H ^d   McGorry, P D ^a,b   Berk, M ^a,b,e,h,i  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f VICTORIA UNIVERSITY   (Australia)

^g DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^h DEAKIN UNIVERSITY   (Australia)

ⁱ BARWON HEALTH   (Australia)

Author keywords

Bipolar disorder; Cognition; Early intervention; Lithium; Mania; Quetiapine

Indexed keywords

LITHIUM; QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; COGNITION; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ILLNESS TRAJECTORY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL PATIENT; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ADOLESCENT; BIPOLAR DISORDER; DRUG EFFECTS; INTELLIGENCE; LEARNING; MEMORY; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COGNITION; DIBENZOTHIAZEPINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE; LITHIUM COMPOUNDS; MALE; MEMORY; QUETIAPINE FUMARATE; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; VERBAL LEARNING; YOUNG ADULT;

EID: 84953210811     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2015.09.460     Document Type: Article

References (41)

1. Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 2015, 20(6):661-670. [Epub 2015/02/18].
2. Allin M.P., Marshall N., Schulze K., Walshe M., Hall M.H., Picchioni M., et al. A functional MRI study of verbal fluency in adults with bipolar disorder and their unaffected relatives. Psychol Med 2010, 40(12):2025-2035. [Epub 2010/02/12].
3. APA Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 2002, 159(4 Suppl.):1-50.
4. Atmaca M., Yildirim H., Ozdemir H., Ogur E., Tezcan E. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 2007, 37(1):121-129. [Epub 2006/11/11].
5. Bearden C.E., Glahn D.C., Caetano S., Olvera R.L., Fonseca M., Najt P., et al. Evidence for disruption in prefrontal cortical functions in juvenile bipolar disorder. Bipolar Disord 2007, 9(Suppl. 1):145-159. [Epub 2007/11/22].
6. Berger G.E., Wood S.J., Ross M., Hamer C.A., Wellard R.M., Pell G., et al. Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr Pharm Des 2012, 18(4):570-575. [Epub 2012/01/14].
7. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011, 35(3):804-817. [Epub 2010/10/12].
8. Bian Q., Kato T., Monji A., Hashioka S., Mizoguchi Y., Horikawa H., et al. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(1):42-48. [Epub 2007/08/25].
9. Bora E., Yucel M., Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009, 113(1-2):1-20. [Epub 2008/08/08].
10. Bourne C., Aydemir O., Balanza-Martinez V., Bora E., Brissos S., Cavanagh J.T., et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand 2013, 128(3):149-162. [Epub 2013/04/27].
11. Bowden C.L., Grunze H., Mullen J., Brecher M., Paulsson B., Jones M., et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005, 66(1):111-121. [Epub 2005/01/27].
12. Calabrese J.R., Keck P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005, 162(7):1351-1360. [Epub 2005/07/05].
13. Daglas R., Yucel M., Cotton S., Allott K., Hetrick S., Berk M. Cognitive impairment in first episode mania: a systematic review of the evidence. Int J Bipolar Disord 2015, 3(9).
14. Daglas R,K. Allott, M. Yucel, L.P. Henry, C.A. Macneil, M.K. Hasty, et al. Cognitive functioning following stabilsation from first episode mania. Manuscript submitted for publication 2015.
15. de Sousa R.T., van de Bilt M.T., Diniz B.S., Ladeira R.B., Portela L.V., Souza D.O., et al. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 2011, 494(1):54-56. [Epub 2011/03/03].
16. Forester B.P., Finn C.T., Berlow Y.A., Wardrop M., Renshaw P.F., Moore C.M. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord 2008, 10(6):691-700. [Epub 2008/10/08].
17. Geddes J.R., Burgess S., Hawton K., Jamison K., Goodwin G.M. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004, 161(2):217-222. [Epub 2004/02/03].
18. Ghaemi S.N., Sachs G.S., Chiou A.M., Pandurangi A.K., Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J Affect Disord 1999, 52(1-3):135-144. [Epub 1999/06/05].
19. Hajek T., Bauer M., Pfennig A., Cullis J., Ploch J., O'Donovan C., et al. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci 2012, 37(3):185-192. [Epub 2012/02/23].
20. Hallahan B., Newell J., Soares J.C., Brambilla P., Strakowski S.M., Fleck D.E., et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry 2011, 69(4):326-335. [Epub 2010/10/30].
21. Hammers D., Spurgeon E., Ryan K., Persad C., Barbas N., Heidebrink J., et al. Validity of a brief computerized cognitive screening test in dementia. J Geriatr Psychiatry Neurol 2012, 25(2):89-99. [Epub 2012/06/13].
22. Kessing L.V., Vradi E., Andersen P.K. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry 2014, 205(3):214-220. [Epub 2014/07/12].
23. Kozicky J.M., Torres I.J., Bond D.J., Lam R.W., Yatham L.N. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. Int Clin Psychopharmacol 2012, 27(2):91-99. [Epub 2011/11/30].
24. Lebowitz B.K., Shear P.K., Steed M.A., Strakowski S.M. Verbal fluency in mania: relationship to number of manic episodes. Neuropsychiatry Neuropsychol Behav Neurol 2001, 14(3):177-182.
25. Lee R.S., Hermens D.F., Scott J., Redoblado-Hodge M.A., Naismith S.L., Lagopoulos J., et al. A meta-analysis of neuropsychological functioning in first-episode bipolar disorders. J Psychiatr Res 2014, 57C:1-11. [Epub 2014/07/14].
26. Levine A.J., Miller E.N., Becker J.T., Selnes O.A., Cohen B.A. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol 2004, 18(3):373-384. [Epub 2005/03/03].
27. Lezak M.D. Neuropsychological assessment 2004, Oxford University Press. Fourth ed.
28. Lopez-Jaramillo C., Lopera-Vasquez J., Ospina-Duque J., Garcia J., Gallo A., Cortez V., et al. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry 2010, 71(8):1055-1060. [Epub 2010/04/07].
29. Miura T., Noma H., Furukawa T.A., Mitsuyasu H., Tanaka S., Stockton S., et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2014, 1(5):351-359. [Epub 2015/09/12].
30. Muralidharan K., Kozicky J.M., Bucker J., Silveira L.E., Torres I.J., Yatham L.N. Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study. Eur Neuropsychopharmacol 2015, 25(2):223-230. [Epub 2014/09/28].
31. Murphy B.P., Pang T.Y., Hannan A.J., Proffitt T.M., McConchie M., Kerr M., et al. Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis. Schizophr Res Treat 2014, 2014:719395. [Epub 2014/03/29].
32. Purdon S.E., Malla A., Labelle A., Lit W. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 2001, 26(2):137-149. [Epub 2001/04/09].
33. Rybakowski J.K., Suwalska A. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol 2010, 13(5):617-622. [Epub 2010/04/16].
34. Rybakowski J.K., Permoda-Osip A., Borkowska A. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol 2009, 19(11):791-795. [Epub 2009/07/07].
35. Schimmelmann B.G., Conus P., Edwards J., McGorry P.D., Lambert M. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005, 66(10):1239-1246. [Epub 2005/11/02].
36. Senturk V., Goker C., Bilgic A., Olmez S., Tugcu H., Oncu B., et al. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 2007, 9(Suppl. 1):136-144. [Epub 2007/11/22].
37. Snyder P.J., Werth J., Giordani B., Caveney A.F., Feltner D., Maruff P. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Hum Psychopharmacol 2005, 20(4):263-273. [Epub 2005/05/25].
38. Tabares-Seisdedos R., Balanza-Martinez V., Sanchez-Moreno J., Martinez-Aran A., Salazar-Fraile J., Selva-Vera G., et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord 2008, 109(3):286-299. [Epub 2008/02/22].
39. Torrent C., Martinez-Aran A., Daban C., Amann B., Balanza-Martinez V., del Mar Bonnin C., et al. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry 2011, 52(6):613-622. [Epub 2011/02/08].
40. Wingo A.P., Wingo T.S., Harvey P.D., Baldessarini R.J. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009, 70(11):1588-1597. [Epub 2009/08/20].
41. Xu H., Chen Z., He J., Haimanot S., Li X., Dyck L., et al. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 2006, 16(6):551-559. [Epub 2006/05/03].